ViroGates A/S Current Liabilities
The Current Liabilities of ViroGates A/S (VIRO.CO) as of Oct 11, 2026 is 7.86 M DKK. In the previous year, Current Liabilities was 3.62 M DKK — a change of 117.08% (higher).
Get this data via API
Financial Data API
Current Liabilities
7.86 MDKK
YoY
117.08%
Last updated:
The ViroGates A/S Current Liabilities history
3 Years
10 Years
25 Years
Max
| YEAR | Current Liabilities | YoY |
|---|---|---|
| 7.86 MDKK | +117.08% | |
| 3.62 MDKK | +60.99% | |
| 2.25 MDKK | +54.93% | |
| 1.45 MDKK | -61.85% | |
| 3.80 MDKK | -45.14% | |
| 6.93 MDKK | +135.62% | |
| 2.94 MDKK | +21.97% | |
| 2.41 MDKK | +21.76% | |
| 1.98 MDKK | -34.23% | |
| 3.01 MDKK | -0.46% | |
| 3.03 MDKK | — |
ViroGates A/S Stock analysis
Frequently Asked Questions about ViroGates A/S stock
Current Liabilities of ViroGates A/S is 7.86 M DKK in 2025.
Current Liabilities of ViroGates A/S changed from 3.62 M DKK to 7.86 M DKK, representing a 117.08% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of Current Liabilities ViroGates A/S since 2006 – with annual values, charts, and detailed analysis.
Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.
Current Liabilities's DKK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's ViroGates A/S historically and in real time.
Balance Sheet — ViroGates A/S
All Key Metrics — ViroGates A/S
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth